Mediwelcome Healthcare Management & Technology Inc. (2159.HK)
HKD 0.44
(-1.14%)
HKD 0.44
(-1.14%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -74.52 Million CNY | 21.97% |
| 2022 | -69.08 Million CNY | -477.83% |
| 2021 | 17.71 Million CNY | -56.85% |
| 2020 | 41.05 Million CNY | -3.38% |
| 2019 | 42.49 Million CNY | -27.22% |
| 2018 | 57.76 Million CNY | 21.91% |
| 2017 | 46.6 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -10.95 Million CNY | 0.0% |
| 2024 Q1 | -10.95 Million CNY | 45.49% |
| 2023 Q3 | -19.18 Million CNY | -13.87% |
| 2023 FY | - CNY | 21.97% |
| 2023 Q1 | -16.85 Million CNY | 24.54% |
| 2023 Q2 | -16.85 Million CNY | 0.0% |
| 2023 Q4 | -20.09 Million CNY | -4.71% |
| 2022 Q2 | -22.02 Million CNY | 0.0% |
| 2022 FY | - CNY | -477.83% |
| 2022 Q4 | -22.33 Million CNY | -3.93% |
| 2022 Q3 | -21.48 Million CNY | 2.46% |
| 2022 Q1 | -22.02 Million CNY | -335.54% |
| 2021 Q4 | 9.35 Million CNY | -6.09% |
| 2021 Q3 | 9.95 Million CNY | 631.16% |
| 2021 Q2 | -1.87 Million CNY | 0.0% |
| 2021 Q1 | -1.87 Million CNY | -111.76% |
| 2021 FY | - CNY | -56.85% |
| 2020 Q1 | 1.5 Million CNY | -89.29% |
| 2020 Q2 | 1.5 Million CNY | 0.0% |
| 2020 FY | - CNY | -3.38% |
| 2020 Q3 | 15.94 Million CNY | 957.83% |
| 2020 Q4 | 15.94 Million CNY | 0.0% |
| 2019 Q3 | 14.07 Million CNY | 124.38% |
| 2019 FY | - CNY | -27.22% |
| 2019 Q1 | 6.27 Million CNY | 0.0% |
| 2019 Q4 | 14.07 Million CNY | 0.0% |
| 2019 Q2 | 6.27 Million CNY | 0.0% |
| 2018 FY | - CNY | 21.91% |
| 2017 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|